Wollenberg, A.; Cork, M.; Hong, C.-H.; Kurbasic, A.; Vacko, E.; Paller, A. Progressive and Sustained Disease Control in Patients With Atopic Dermatitis (AD) Aged 12–17 Years Treated With Tralokinumab for 52 Weeks. J of Skin 2024, 8, s377.